Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppression After Kidney Transplantation”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Post-approval studies (Phase 4)WithdrawnNCT03315052
What this trial is testing

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

Who this might be right for
Acute Cellular Graft RejectionLiver Transplant Rejection
Montefiore Medical Center
Post-approval studies (Phase 4)Study completedNCT00807144
What this trial is testing

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

Who this might be right for
End-stage Renal FailureGraft Rejection
Imperial College Healthcare NHS Trust 102
Not applicableNot Yet RecruitingNCT07231328
What this trial is testing

PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)

Who this might be right for
Immunosuppression ManagementBiomarkers / BloodSubclinical Rejection+2 more
Transplant Genomics, Inc. 600
Large-scale testing (Phase 3)Ended earlyNCT04063865
What this trial is testing

Everolimus Monotherapy as Immunosuppression After Liver Transplant

Who this might be right for
Kidney Failure
Indiana University 14
Post-approval studies (Phase 4)UnknownNCT01550445
What this trial is testing

Steroid Withdrawal Immunosuppression After Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Ajou University School of Medicine 30
Post-approval studies (Phase 4)Study completedNCT02560558
What this trial is testing

Bela 8 Week Dosing

Who this might be right for
Kidney Transplantation
Emory University 166
Not applicableStudy completedNCT04189835
What this trial is testing

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Who this might be right for
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more
University of Aarhus 509
Not applicableUnknownNCT00461357
What this trial is testing

Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program

Who this might be right for
Kidney Function After TransplantationOutcome After Kidney Transplantation
Medical University of Vienna 48
Early research (Phase 1)WithdrawnNCT03047200
What this trial is testing

Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

Who this might be right for
Islet Cell TransplantationType 1 Diabetes
Baylor Research Institute
Post-approval studies (Phase 4)Study completedNCT01935128
What this trial is testing

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Who this might be right for
Renal Transplant
University of Toledo Health Science Campus 55
Post-approval studies (Phase 4)Study completedNCT03216967
What this trial is testing

Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

Who this might be right for
BK Virus Nephropathy After Kidney Transplantation
University Hospital, Strasbourg, France 130
Testing effectiveness (Phase 2)Ended earlyNCT00555789
What this trial is testing

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 137
Testing effectiveness (Phase 2)Study completedNCT01062555
What this trial is testing

Calcineurin Inhibitor Sparing After Kidney Transplantation

Who this might be right for
CNI Side Effects
University of Minnesota 527
Post-approval studies (Phase 4)UnknownNCT00204191
What this trial is testing

Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

Who this might be right for
Kidney Transplantation
Uniwersytet Mikolaja Kopernika w Toruniu 300
Testing effectiveness (Phase 2)Study completedNCT00001984
What this trial is testing

Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys

Who this might be right for
Graft RejectionKidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05285878
What this trial is testing

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more
The Methodist Hospital Research Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01909245
What this trial is testing

Islet Cell Transplant for Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
City of Hope Medical Center 10
Not applicableUnknownNCT04733131
What this trial is testing

Long-term Outcomes After Conversion to Belatacept

Who this might be right for
Kidney Transplant Failure and RejectionImmunosuppressionGraft Loss+1 more
Paris Translational Research Center for Organ Transplantation 324
Testing effectiveness (Phase 2)Study completedNCT04114188
What this trial is testing

Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)

Who this might be right for
Renal Transplant Rejection
Prof. Dr. Petra Reinke 68
Post-approval studies (Phase 4)UnknownNCT03005236
What this trial is testing

AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation

Who this might be right for
Kidney Transplant Failure and Rejection
University Hospital Birmingham NHS Foundation Trust 40
Load More Results